- All sections
- G - Physics
- G01N - Investigating or analysing materials by determining their chemical or physical properties
- G01N 33/50 - Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
Patent holdings for IPC class G01N 33/50
Total number of patents in this class: 22853
10-year publication summary
1622
|
1628
|
1914
|
1978
|
1968
|
1854
|
1678
|
1646
|
1411
|
878
|
2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
The Regents of the University of California | 19150 |
369 |
President and Fellows of Harvard College | 5838 |
235 |
Massachusetts Institute of Technology | 9834 |
183 |
The Board of Trustees of the Leland Stanford Junior University | 6111 |
182 |
Dana-Farber Cancer Institute, Inc. | 2493 |
170 |
The Johns Hopkins University | 5425 |
160 |
Centre National de La Recherche Scientifique | 9798 |
142 |
Inserm (institut National de La Sante et de La Recherche Medicale) | 3332 |
142 |
The General Hospital Corporation | 4572 |
136 |
F. Hoffmann-La Roche AG | 7959 |
123 |
Osaka University | 3216 |
123 |
The University of Tokyo | 3969 |
116 |
Immatics Biotechnologies GmbH | 1157 |
115 |
Kyoto University | 2755 |
113 |
Regeneron Pharmaceuticals, Inc. | 3821 |
106 |
Institut National de La Sante et de La Recherche Medicale (inserm) | 2460 |
105 |
Board of Regents, The University of Texas System | 5472 |
92 |
Genentech, Inc. | 3750 |
86 |
The Broad Institute, Inc. | 1637 |
85 |
The Brigham and Women's Hospital, Inc. | 2109 |
83 |
Other owners | 19987 |